These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 22275833)
1. Investigation of nano lipid vesicles of methotrexate for anti-rheumatoid activity. Prabhu P; Shetty R; Koland M; Vijayanarayana K; Vijayalakshmi KK; Nairy MH; Nisha GS Int J Nanomedicine; 2012; 7():177-86. PubMed ID: 22275833 [TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of lipid vesicles of camptothecin as targeted drug delivery system. Prabhakara P; Zenia T; Marina K; Shama KP; Girish SN; Matapady NH Pak J Pharm Sci; 2013 Jul; 26(4):779-86. PubMed ID: 23811458 [TBL] [Abstract][Full Text] [Related]
3. Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis. Verma A; Jain A; Tiwari A; Saraf S; Panda PK; Agrawal GP; Jain SK Pharm Res; 2019 Jun; 36(8):123. PubMed ID: 31218557 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate Aspasomes Against Rheumatoid Arthritis: Optimized Hydrogel Loaded Liposomal Formulation with In Vivo Evaluation in Wistar Rats. Ghosh S; Mukherjee B; Chaudhuri S; Roy T; Mukherjee A; Sengupta S AAPS PharmSciTech; 2018 Apr; 19(3):1320-1336. PubMed ID: 29340978 [TBL] [Abstract][Full Text] [Related]
5. Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations. Pandey S; Kumar V; Leekha A; Rai N; Ahmad FJ; Verma AK; Talegaonkar S Pharm Res; 2018 Sep; 35(11):201. PubMed ID: 30187188 [TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis. Kumar V; Leekha A; Tyagi A; Kaul A; Mishra AK; Verma AK Pharm Res; 2017 Mar; 34(3):654-667. PubMed ID: 28097508 [TBL] [Abstract][Full Text] [Related]
8. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities. Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539 [TBL] [Abstract][Full Text] [Related]
9. Prolonged blood circulation of methotrexate by modulation of liposomal composition. Hong MS; Lim SJ; Lee MK; Kim YB; Kim CK Drug Deliv; 2001; 8(4):231-7. PubMed ID: 11757781 [TBL] [Abstract][Full Text] [Related]
10. Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation. Adin SN; Gupta I; Aqil M; Mujeeb M; Najmi AK J Drug Target; 2024 Jul; 32(6):707-723. PubMed ID: 38652489 [No Abstract] [Full Text] [Related]
11. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Zeb A; Qureshi OS; Yu CH; Akram M; Kim HS; Kim MS; Kang JH; Majid A; Chang SY; Bae ON; Kim JK Int J Pharm; 2017 Jun; 525(1):92-100. PubMed ID: 28428089 [TBL] [Abstract][Full Text] [Related]
12. Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation. Sadarani B; Majumdar A; Paradkar S; Mathur A; Sachdev S; Mohanty B; Chaudhari P Biomed Pharmacother; 2019 Jun; 114():108770. PubMed ID: 30913494 [TBL] [Abstract][Full Text] [Related]
13. A single intra-articular injection of liposomally conjugated methotrexate suppresses joint inflammation in rat antigen-induced arthritis. Williams AS; Camilleri JP; Goodfellow RM; Williams BD Br J Rheumatol; 1996 Aug; 35(8):719-24. PubMed ID: 8761182 [TBL] [Abstract][Full Text] [Related]
14. pH-responsive size-adjustable liposomes induce apoptosis of fibroblasts and macrophages for rheumatoid arthritis treatment. Zheng X; Yang H; Zhang Z; Liang X; Liu Y; Wang C; Yang X; Tang J; Mao J; Nie Y; Zhou X; Li C Acta Biomater; 2024 Apr; 179():256-271. PubMed ID: 38484831 [TBL] [Abstract][Full Text] [Related]
15. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis. Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513 [TBL] [Abstract][Full Text] [Related]
16. Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles. Ait Bachir Z; Huang Y; He M; Huang L; Hou X; Chen R; Gao F Int J Nanomedicine; 2018; 13():5657-5671. PubMed ID: 30288039 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Chen J; Huang L; Lai H; Lu C; Fang M; Zhang Q; Luo X Mol Pharm; 2014 Jul; 11(7):2213-23. PubMed ID: 24164427 [TBL] [Abstract][Full Text] [Related]
19. Surface saturation of drug-loaded hollow manganese dioxide nanoparticles with human serum albumin for treating rheumatoid arthritis. Jia M; Ren W; Wang M; Liu Y; Wang C; Zhang Z; Xu M; Ding N; Li C; Yang H Drug Deliv; 2024 Dec; 31(1):2380538. PubMed ID: 39044468 [TBL] [Abstract][Full Text] [Related]
20. The Impact of Liposomal Formulations on the Release and Brain Delivery of Methotrexate: An In Vivo Microdialysis Study. Hu Y; Rip J; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M J Pharm Sci; 2017 Sep; 106(9):2606-2613. PubMed ID: 28322936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]